Clarity Pharmaceuticals Stock Market Value

Clarity Pharmaceuticals appears to be dangerous, given 3 months investment horizon. Clarity Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.05, which signifies that the company had a 0.05 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Clarity Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of Clarity Pharmaceuticals' risk adjusted performance of 0.0621, and Mean Deviation of 3.39 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Clarity Pharmaceuticals holds a performance score of 3. The firm shows a Beta (market volatility) of 0.18, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Clarity Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Clarity Pharmaceuticals is expected to be smaller as well. Please check Clarity Pharmaceuticals' value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to make a quick decision on whether Clarity Pharmaceuticals' price patterns will revert.